Clal Insurance’s Delek US DK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-201,982
Closed -$5.74M 129
2023
Q3
$5.74M Buy
201,982
+51,982
+35% +$1.4M 0.08% 76
2023
Q2
$3.59M Hold
150,000
0.04% 97
2023
Q1
$3.44M Hold
150,000
0.05% 98
2022
Q4
$4.05M Hold
150,000
0.06% 107
2022
Q3
$4.07M Hold
150,000
0.06% 114
2022
Q2
$3.88M Buy
+150,000
New +$4.05M 0.05% 115
2020
Q1
Sell
-19,321
Closed -$576K 128
2019
Q4
$576K Sell
19,321
-697,525
-97% -$25.2M 0.62% 45
2019
Q3
$26M Sell
716,846
-330,157
-32% -$12.2M 0.63% 47
2019
Q2
$42.4M Sell
1,047,003
-2,311
-0.2% -$84.6K 0.98% 41
2019
Q1
$38.2M Buy
1,049,314
+289,314
+38% +$9.85M 0.94% 36
2018
Q4
$24.7M Buy
760,000
+410,000
+117% +$15.5M 0.64% 38
2018
Q3
$14.8M Buy
+350,000
New +$17.3M 0.39% 37

Other funds holding DK

Clal Insurance's DK Position: Q4 2023 in Review

Clal Insurance sold out of Delek US (DK) in Q4 2023, closing a stake of 201,982 shares — an estimated $5.74M sold.

Clal Insurance first reported a position in DK in Q3 2018 and held it in 12 quarters. The position peaked at $42.4M in Q2 2019. 222 funds tracked by Wall St. Rank hold DK as of Q4 2023.

  • Clal Insurance reported no remaining Delek US position as of Q4 2023 after selling out during the quarter.
  • Clal Insurance sold 201,982 Delek US shares in Q4 2023, an estimated $5.74M.
  • Clal Insurance first reported a position in Delek US in Q3 2018 and held it in 12 quarters.
  • Clal Insurance's Delek US position peaked at $42.4M in Q2 2019.
  • 222 funds tracked by Wall St. Rank held Delek US as of Q4 2023.

Based on Clal Insurance's 13F filing for Q4 2023, filed 14 Feb 2024.